Serum soluble triggering receptor expressed on myeloid cells‐2 was not altered by rTMS in patients with treatment‐resistant depression

Serum soluble triggering receptor expressed on myeloid cells‐2 was not altered by rTMS in patients with treatment‐resistant depression

Abstract Aim Repetitive transcranial magnetic stimulation (rTMS) is one of the most effective and minimally invasive treatments for treatment‐resistant depression (TRD). However, the mechanism underlying the therapeutic effects of rTMS in patients with TRD remains unclear. In recent years, the patho...

Full description

Bibliographic Details
Main Authors: Hiroshi Tateishi, Jun Matsushima, Hiroko Kunitake, Yoshiomi Imamura, Yutaka Kunitake, Toru Murakawa, Seiji Mawatari, Ryohei Kojima, Yuka Fujii, Jun Kikuchi, Junko Fukuchi, Yuta Sakemura, Takumi Shiraishi, Chika Nagahama, Toshihiko Maekawa, Toyoko Asami, Yoshito Mizoguchi, Akira Monji
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Neuropsychopharmacology Reports
Subjects:
cognitive dysfunction
repetitive transcranial magnetic stimulation
treatment‐resistant depression
triggering receptor expressed on myeloid cells‐2
Online Access:https://doi.org/10.1002/npr2.12332

Internet

https://doi.org/10.1002/npr2.12332

Similar Items